Cleveland Diagnostics, Inc. is a privately held company that specializes in the development and commercialization of advanced cancer diagnostics. The company's innovative technology platform, IsoPSA, utilizes isomer specific PSA testing to improve the detection and management of prostate cancer.

Cleveland Diagnostics is developing a breakthrough technology to discover a new class of diagnostics tests with high sensitivity and specificity for many cancers – early on, when cancer is still curable.

COM:CLEVELANDDX

Cleveland Diagnostics, Inc.

Analysis Not Available